EP2651410 - TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING AN ACTIVE SUBSTANCE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 20.08.2021 Database last updated on 24.08.2024 | |
Former | The patent has been granted Status updated on 11.09.2020 | ||
Former | Grant of patent is intended Status updated on 05.05.2020 | ||
Former | Examination is in progress Status updated on 28.07.2017 | Most recent event Tooltip | 08.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 10.08.2022 [2022/32] | Applicant(s) | For all designated states Luye Pharma AG Am Windfeld 35 83714 Miesbach / DE | [2017/12] |
Former [2013/43] | For all designated states Acino AG Am Windfeld 35 83714 Miesbach / DE | Inventor(s) | 01 /
LANGER, Britta Alte Brauerei 12 10965 Berlin / DE | 02 /
SCHURAD, Bjoern Michael-Huber-Weg 26 81667 München / DE | 03 /
PRINZ, Heike Malvenweg 16 82008 Unterhaching / DE | [2013/43] | Representative(s) | Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstraße 2 80538 München / DE | [N/P] |
Former [2020/42] | Kalhammer, Georg, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE | ||
Former [2013/43] | Kalhammer, Georg, et al Lederer & Keller Patentanwälte Unsöldstrasse 2 80538 München / DE | Application number, filing date | 11799413.7 | 14.12.2011 | [2020/42] | WO2011EP72812 | Priority number, date | EP20100194968 | 14.12.2010 Original published format: EP 10194968 | [2013/43] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO2012080365 | Date: | 21.06.2012 | Language: | DE | [2012/25] | Type: | A1 Application with search report | No.: | EP2651410 | Date: | 23.10.2013 | Language: | DE | The application published by WIPO in one of the EPO official languages on 21.06.2012 takes the place of the publication of the European patent application. | [2013/43] | Type: | B1 Patent specification | No.: | EP2651410 | Date: | 14.10.2020 | Language: | DE | [2020/42] | Search report(s) | International search report - published on: | EP | 21.06.2012 | Classification | IPC: | A61K9/70, A61K31/27, A61P17/00, A61P25/16, A61P25/28 | [2020/21] | CPC: |
A61K9/7084 (EP,CN,US);
A61K9/70 (KR);
A61K31/27 (EP,CN,KR,US);
A61K47/32 (CN);
A61P17/00 (EP);
A61P25/16 (EP);
A61P25/28 (EP)
(-)
|
Former IPC [2013/43] | A61K31/27, A61K9/00, A61K9/70 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/43] | Extension states | BA | 12.07.2013 | ME | 12.07.2013 | Title | German: | TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR VERABREICHUNG EINES WIRKSTOFFS | [2013/43] | English: | TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING AN ACTIVE SUBSTANCE | [2013/43] | French: | SYSTÈME THÉRAPEUTIQUE TRANSDERMIQUE POUR L'ADMINISTRATION D'UN PRINCIPE ACTIF | [2013/43] | Entry into regional phase | 05.07.2013 | National basic fee paid | 05.07.2013 | Designation fee(s) paid | 05.07.2013 | Examination fee paid | Examination procedure | 05.07.2013 | Examination requested [2013/43] | 14.02.2014 | Amendment by applicant (claims and/or description) | 28.07.2017 | Despatch of a communication from the examining division (Time limit: M06) | 06.02.2018 | Reply to a communication from the examining division | 03.07.2019 | Despatch of a communication from the examining division (Time limit: M04) | 13.11.2019 | Reply to a communication from the examining division | 06.05.2020 | Communication of intention to grant the patent | 31.08.2020 | Fee for grant paid | 31.08.2020 | Fee for publishing/printing paid | 31.08.2020 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 28.07.2017 | Opposition(s) | 15.07.2021 | No opposition filed within time limit [2021/38] | Fees paid | Renewal fee | 23.12.2013 | Renewal fee patent year 03 | 18.12.2014 | Renewal fee patent year 04 | 26.11.2015 | Renewal fee patent year 05 | 24.11.2016 | Renewal fee patent year 06 | 07.11.2017 | Renewal fee patent year 07 | 27.11.2018 | Renewal fee patent year 08 | 21.11.2019 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 14.10.2020 | MK | 14.10.2020 | [2022/32] |
Former [2021/45] | AL | 14.10.2020 | Cited in | International search | [XDI]DE19918106 (LOHMANN THERAPIE SYST LTS [DE]) [XD] 56-61 * page 2, line 3 - page 3, line 37 * * page 4, line 7 - page 5, line 65 * * claims 1, 2, 5, 6, 24, 26 * * figure 5 * [I] 1-16,31,47-61; | [AD]WO2007064407 (NOVARTIS AG [CH], et al) [AD] 1-61 * page 1, paragraph 1 - page 3, paragraph 5 * * page 6, paragraph 1 - paragraph 4 * * page 7, paragraph 4 - paragraph 5 * * page 8, paragraph 4 - page 9, paragraph 1 * * example I. * * claims 1, 3, 9-11, 15, 20 *; | [XI]US2008175890 (YUM SU IL [US], et al) [X] 17,18,22-30,47,48,50-55 * page 10, paragraph 0077 - page 11, paragraph 0083 * * page 12, paragraphs 0089-0092 * * page 14, paragraph 0101 - page 15, paragraph 0111 * * figure 2 * * claim - * [I] 19; | [XI]WO2009009651 (AGILE THERAPEUTICS INC [US], et al) [X] 17-19,22-30,47-49 * page 2, lines 17-30 * * page 4, line 19 - page 5, line 3 * * page 5, line 24 - page 6, line 15 * * page 9, line 19 - page 10, line 15 * * figure - *[I] 50-55; | [XDI]EP2016939 (TEIKOKU SEIYAKU KK [JP]) [XD] 1,3-5,9,14-16,32-58,60 * page 1, paragraph 0002 * * page 3, paragraph 0013 - paragraph 0015 * * page 3, paragraph 0016; figure 2 * * page 3, paragraph 0018 - page 5, paragraph 0041 * * page 7, paragraph 0064 - page 8, paragraph 0075 * * claims 1, 3, 6 * [I] 1-16,31,41-61; | [XI]WO2009026135 (ALZA CORP [US], et al) [X] 17-19,21-23,25-30,50-55 * page 5, paragraph 00013 - page 6, paragraph 00014 * * page 11, paragraph 00039 - page 13, paragraph 00043 * * page 15, paragraph 00047 - page 17, paragraph 00053 * * page 25, paragraphs 00069-00070 * * example 2 * * figures 1-2 * [I] 20 | by applicant | GB2203040 | DE19918106 | EP1047409 | WO0203969 | WO03017988 | US6689379 | US2004086552 | WO2007064407 | US2007259028 | WO2008021113 | US2008044461 | EP2016939 | - "OECD GUIDELINE FOR THE TESTING OF CHEMICALS. Skin Absorption: in vitro method.", TEST GUIDELINE, (20040413), vol. 428, pages 1 - 8 |